Pharma and government health officials are luring parents and teens into getting the vaccine by promising a return to social events and normal life — while ignoring potential harms and the “miniscule” risk COVID poses to children.
A decade ago, Ohio researchers bemoaned the difficulty of recruiting children for clinical trials. In the article, “Pediatric Drug-Trial Recruitment: Enticement Without Coercion,” published in the journal Pediatrics, researchers identified barriers such as “the challenge of determining appropriate payments for participation that are not coercive,” “the need to obtain consent from parents” and “ethical concerns.”
With COVID-19, it appears the government and pharma may have determined they can simply leapfrog over these pesky obstacles. On May 10, the U.S. Food and Drug Administration (FDA) extended the FDA’s Emergency Use Authorization (EUA) for the Pfizer/BioNTech COVID vaccine to adolescents 12 through 15 years of age.
The FDA committee that steered the decision chose to ignore urgent warnings from around the world about the vaccine’s risks for children, including a letter by 93 Israeli doctors who wrote in April that “not even a handful of children should be endangered through mass vaccination against a disease that is not dangerous to them.”
According to a recent New York Times article, “For children, the evidence so far does not offer much reason for alarm about COVID-19’s long-term effects.” Conversely, the Israeli doctors and other experts have emphasized that “it cannot be ruled out that the vaccine will have long-term adverse effects that have not yet been discovered at this time, including on growth, reproductive system or fertility.”